Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Unmet Needs in nAMD in 2026
Szilard Kiss, MD
Carl D. Regillo, MD, FACS, FASRS
How Gene Therapy Is Designed to Work in Retinal Disease
Lejla Vajzovic, MD, FASRS
Beyond Anti-VEGF: The Emerging Durability Landscape
Gene Therapy for nAMD: Focus on Future Readiness
Seeing the Cornea Clearly
Jacob Lang
Seeing the Signs of Dry Eye Disease
Steve Jackson, PharmD
John D. Sheppard, MD
Geographic Atrophy: A Personalized Approach
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Jonisch, MD
EMPOWER - Ocular Surface Disease: Latest Innovations In Dry Eye And Meibomian Gland Dysfunction
Josh Davidson, OD, FSLS, FAAO
Mark Dunbar
Interpreting Gene Therapy Data With Confidence
Adverse Event Mitigation in Gene Therapy for nAMD
Uncovering the Drivers of Dry Eye Symptoms
Anat Galor, MD, MSPH
Rethinking Dry Eye Disease: Evolving Strategies for Evaluation and Care
Esen K. Akpek, MD
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
Extended Dosing Strategies for Diabetic Retinopathy and DME
Michael A. Klufas, MD
Optimizing Anti-VEGF Selection in Diabetic Macular Edema
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.